RecruitingNCT05177393

Treatment Outcomes of Esophageal Cancer

Sponsor

University of California, San Francisco

Enrollment

2,476 participants

Start Date

Feb 28, 2019

Study Type

OBSERVATIONAL

Conditions

Esophageal Cancer

Summary

This study will be a carried out through a prospective observational cohort design in conjunction with researchers in the African Esophageal Cancer Consortium (AfrECC). The purpose of this research is to prospectively evaluate outcomes related to existing treatment strategies for esophageal cancer (EC) at participating sites within AfrECC.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry and outcomes study — not a treatment trial — tracking real-world treatment results in patients with esophageal cancer. Researchers will collect data about what treatments patients received and how they did over time. **You may be eligible if:** - You are 18 years or older - You have been diagnosed with esophageal cancer, either confirmed by biopsy or strongly suspected based on imaging or endoscopy - You are able to give informed consent **You may NOT be eligible if:** - You are unable to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.